1. The FDA is on track to approve the most generic drugs ever in its fiscal year of 2017. The regulator has approved 633 generic drugs so far this year, compared to 651 in its 2016 fiscal year. (RAPS)
2. CVS Health president and CEO Larry Merlo told analysts he doesn’t expect Amazon to enter the pharmacy business. Merlo cited regulations as a significant barrier to entry for the retail giant. (Forbes)
3. Elias Zerhouni, Sanofi’s president of global R&D, said not to discount the Paris-based drugmaker just yet in the market to develop cancer immunotherapies. The company has plans to bring a PD-1 inhibitor to market as a treatment for lung cancer. (Bloomberg)
4. Mylan cut its profit forecast for 2017 and 2018, citing delays in bringing new drugs to market and declining generic drug prices in the U.S. (Reuters)
5. In other CVS Health news, a woman in California sued the PBM, accusing the company of overbilling customers who used insurance to pay for generic drugs when paying in cash would have been cheaper than her copay. The woman was charged $166 for a generic drug using her insurance. Paying directly would have cost her $92. (Bloomberg)
